Literature DB >> 19175794

The acute-phase response impairs host defence against Enterococcus faecium peritonitis.

Masja Leendertse1, Rob J L Willems, Ida A J Giebelen, Petra S van den Pangaart, Marc J M Bonten, Tom van der Poll.   

Abstract

Enterococcus faecium is an emerging pathogen that causes infections in hospitalized patients with various co-morbid diseases. These underlying diseases are often associated with an acute-phase response that renders patients vulnerable to nosocomial infections. To study the influence of the acute-phase response induced by sterile tissue injury on host defence against E. faecium, mice were injected subcutaneously with either turpentine or casein 1 day before intraperitoneal infection with E. faecium. Control mice were subcutaneously injected with saline or sodium bicarbonate, respectively. Turpentine and casein induced an acute-phase response as reflected by increases in the plasma concentrations of interleukin-6, serum amyloid P and C3. A pre-existent acute-phase response in mice was associated with a strongly reduced capacity to clear E. faecium, resulting in prolonged bacteraemia for several days. The inflammatory response to E. faecium was impaired in mice with an acute-phase response, as shown by reduced capacity to mount a neutrophilic leucocytosis in peripheral blood and by decreased local cytokine concentrations. These data indicate that the acute-phase response impairs host defence against E. faecium, suggesting that this condition may contribute to the increased vulnerability of critically ill patients to enterococcal infections.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19175794      PMCID: PMC2753956          DOI: 10.1111/j.1365-2567.2008.02967.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  18 in total

Review 1.  Clinical aspects: from systemic inflammation to 'immunoparalysis'.

Authors:  H D Volk; P Reinke; W D Döcke
Journal:  Chem Immunol       Date:  2000

Review 2.  Chemokines and chemokine receptors in leukocyte trafficking.

Authors:  Timothy S Olson; Klaus Ley
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2002-07       Impact factor: 3.619

3.  The acute-phase response protects mice from D-galactosamine sensitization to endotoxin and tumor necrosis factor-alpha.

Authors:  J M Alcorn; J Fierer; M Chojkier
Journal:  Hepatology       Date:  1992-01       Impact factor: 17.425

4.  Case-control study of risk factors for the development of enterococcal bacteremia.

Authors:  F J Caballero-Granado; B Becerril; J M Cisneros; L Cuberos; I Moreno; J Pachón
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2001-02       Impact factor: 3.267

5.  Involvement of the acute phase protein alpha 1-acid glycoprotein in nonspecific resistance to a lethal gram-negative infection.

Authors:  T Hochepied; W Van Molle; F G Berger; H Baumann; C Libert
Journal:  J Biol Chem       Date:  2000-05-19       Impact factor: 5.157

6.  Association between preoperative acute phase response and postoperative complications.

Authors:  W Haupt; W Hohenberger; R Mueller; P Klein; N V Christou
Journal:  Eur J Surg       Date:  1997-01

7.  Reduced TNFalpha and IL-6 production in patients who mount a preoperative acute phase response.

Authors:  W Haupt; H Zirngibl; P Klein; J Riese; W Hohenberger
Journal:  Langenbecks Arch Surg       Date:  1998-03       Impact factor: 3.445

8.  Production of granulocyte colony-stimulating factor in the nonspecific acute phase response enhances host resistance to bacterial infection.

Authors:  Mahdad Noursadeghi; Maria C M Bickerstaff; Jeff Herbert; David Moyes; Jonathan Cohen; Mark B Pepys
Journal:  J Immunol       Date:  2002-07-15       Impact factor: 5.422

Review 9.  Enterococcal bacteremia: clinical features, the risk of endocarditis, and management.

Authors:  D G Maki; W A Agger
Journal:  Medicine (Baltimore)       Date:  1988-07       Impact factor: 1.889

10.  Enterococcus faecium and Enterococcus faecalis bacteremia: acquisition and outcome.

Authors:  G A Noskin; L R Peterson; J R Warren
Journal:  Clin Infect Dis       Date:  1995-02       Impact factor: 9.079

View more
  2 in total

1.  Inhibition of the Classical Pathway of Complement Activation Impairs Bacterial Clearance during Enterococcus faecalis Infection.

Authors:  Youssif M Ali; Ramadan Hassan; Eman M Rabie Shehab El-Din; Abdelaziz Elgaml
Journal:  Infect Immun       Date:  2021-04-16       Impact factor: 3.441

2.  Enterococcus faecalis overcomes foreign body-mediated inflammation to establish urinary tract infections.

Authors:  Pascale S Guiton; Thomas J Hannan; Bradley Ford; Michael G Caparon; Scott J Hultgren
Journal:  Infect Immun       Date:  2012-11-06       Impact factor: 3.441

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.